VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
Fructose Intolerance
Role of gastrografin challenge in early postoperative small bowel obstruction.
Thymosin
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials. Lancet. 2022 08 13; 400(10351):512-521.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase I as Topic
Drugs, Investigational
Female
Humans
Male
National Cancer Institute (U.S.)
Neoplasms
United States